Scenic Biotech
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
Scenic Biotech has raised €28M across 1 funding round from 7 investors, most recently a Series A round in Mar 2022. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Amsterdam, Netherlandswww.scenicbiotech.com ↗
Total raised
€28M
€28,000,000
Funding rounds
1
Investors
7
distinct backers
Active since
2022-03
latest 2022-03
Funding by year
EUR raised per yearScenic Biotech — funding by year — interactive chart.
Data table
| Scenic Biotech — funding by year | |
|---|---|
| 2022 | €28M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-10 | Series A | €28M | BioGeneration Ventures,BioMedPartners,EIR Ventures,INKEF Capital,Nordic Life Science,Oxford Science Enterprises+1 more | View deal → |
Investors
7Related news
- Amsterdam’s Scenic Biotech raises €28M to specialise in evolution-inspired medicine for rare diseasessiliconcanals.com · 2022-03
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData